SITE001-0267

SITE001 (USA) › SITE001-0267

SITE001-0267

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2026-07-17

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-03-01 (study day 38); relationship: NOT RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.